U.S. Markets open in 7 hrs 35 mins

The AngioDynamics (NASDAQ:ANGO) Share Price Has Gained 88% And Shareholders Are Hoping For More

Simply Wall St

By buying an index fund, you can roughly match the market return with ease. But if you buy good businesses at attractive prices, your portfolio returns could exceed the average market return. For example, AngioDynamics, Inc. ( NASDAQ:ANGO ) shareholders have seen the share price rise 88% over three years, well in excess of the market return (36%, not including dividends). On the other hand, the returns haven’t been quite so good recently, with shareholders up just 28%.

View our latest analysis for AngioDynamics

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company’s share price and its earnings per share (EPS).

AngioDynamics became profitable within the last three years. So we would expect a higher share price over the period.

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

NasdaqGS:ANGO Past and Future Earnings, March 11th 2019

It is of course excellent to see how AngioDynamics has grown profits over the years, but the future is more important for shareholders. You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic .

A Different Perspective

It’s good to see that AngioDynamics has rewarded shareholders with a total shareholder return of 28% in the last twelve months. Since the one-year TSR is better than the five-year TSR (the latter coming in at 5.3% per year), it would seem that the stock’s performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. Before spending more time on AngioDynamics it might be wise to click here to see if insiders have been buying or selling shares.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com . This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.